Safety of ramelteon in individuals with mild to moderate obstructive sleep apneaKRYGER, Meir; WANG-WEIGAND, Sherry; ROTH, Thomas et al.Sleep & breathing. 2007, Vol 11, Num 3, pp 159-164, issn 1520-9512, 6 p.Article

Ramelteon 8 mg/d Versus Placebo in Patients with Chronic Insomnia : Post Hoc Analysis of a 5-Week Trial Using 50% or Greater Reduction in Latency to Persistent Sleep as a Measure of Treatment EffectMINI, Louis; WANG-WEIGAND, Sherry; ZHANG, Jeff et al.Clinical therapeutics. 2008, Vol 30, Num 7, pp 1316-1323, issn 0149-2918, 8 p.Article

Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia : A 1-Year, Open-Label StudyRICHARDSON, Gary S; ZAMMIT, Gary; WANG-WEIGAND, Sherry et al.The Journal of clinical psychiatry. 2009, Vol 70, Num 4, pp 467-476, issn 0160-6689, 10 p.Conference Paper

Effect of Ramelteon, a selective MT₁/MT₂-receptor agonist, on respiration during sleep in mild to moderate COPDKRYGER, Meir; WANG-WEIGAND, Sherry; ZHANG, Jeffrey et al.Sleep & breathing. 2008, Vol 12, Num 3, pp 243-250, issn 1520-9512, 8 p.Article

The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary diseaseKRYGER, Meir; ROTH, Thomas; WANG-WEIGAND, Sherry et al.Sleep & breathing. 2009, Vol 13, Num 1, pp 79-84, issn 1520-9512, 6 p.Article

Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary InsomniaMAYER, Geert; WANG-WEIGAND, Sherry; ROTH-SCHECHTER, Barbara et al.Sleep (New York, NY). 2009, Vol 32, Num 3, pp 351-360, issn 0161-8105, 10 p.Article

In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post mensesHILL, Donna R; BRUNNER, Marianne E; SCHMITZ, Deborah C et al.Journal of applied physiology (1985). 2005, Vol 99, Num 4, pp 1582-1591, issn 8750-7587, 10 p.Article